3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline deriva

Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D48704, A61K 31505

Patent

active

055126774

ABSTRACT:
The present invention provides a novel series of 3-substituted methyl-2,5-dihydroimidazo 1,2-c!quinazoline compounds. These compounds are found useful as an active ingredient for the treatment of hypertension and dysuria.

REFERENCES:
patent: 5120736 (1992-06-01), Houziaux et al.
patent: 5128338 (1992-07-01), Bourguignon et al.
patent: 5158953 (1992-10-01), Chern et al.
Ji-Wang Chern, et al., "Studies On Quinazolines, 3:1 Novel And Efficient . . . ", Biorganic & Medicinal Chemistry Letters, vol. 1, No. 11, pp. 571-574, 1991.
Narihito Seki, et al., "Electrical and Mechanical Properties of the Capsular . . . ", Br. J. Pharmacol, (1988), 93, 702-714.
Yamanouchi, et al., article from Drug of the Future, (1989), p. 400.
Virginia Bogert Schatz, "Isoterism and Bio-isosterism as Guides to Structural Variations", Medicinal Chemistry, Interscience Publishers, Inc., 1960, pp. 72-78, edited by Alfred Burger.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline deriva does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline deriva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline deriva will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-629876

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.